Scientists uncover mode of action of enzyme linked with several types of cancer

Jun 03, 2009

Scientists at the Institute for Research in Immunology and Cancer (IRIC) of the Université de Montréal have discovered a key mechanism used by cells to efficiently distribute chromosomes to new cells during cell multiplication. Published in the journal Molecular Cell, the study is the first to demonstrate that this mechanism relies on the polo kinase, an enzyme implicated in several cancers. Inhibiting this mechanism could be key to developing effective therapies to treat cancer.

Each human cell contains, in its nucleus, all the coding instructions necessary to direct the cell's activities. A complete set of those instructions is referred to as a genome. Cancer are capable of altering their genome in order to promote uncontrolled growth. "Cancer cells achieve this by gaining or losing specific chromosomes, or by inducing structural defects in their genome," explains Damien D'Amours, Principal Investigator at IRIC and director of the study, "We discovered that the polo kinase, overexpressed in a broad range of human tumours, tells the chromosomes exactly when to condense during cell division."

Misregulation of the polo kinase is associated with cancers, thereby suggesting a link between defects in chromosome condensation and the formation of tumours. "Pharmaceutical companies and independent researchers are already working on the development of new cancer drugs to inhibit the activity of the polo kinase," points out Damien D'Amours, "Understanding this enzyme's mode of action should enable us to control it. Such knowledge may reveal itself to be key in developing effective therapies to treat ."

In a preview article commissioned by , world leader in chromosome dynamics Tatsuya Hirano, of the Riken Advanced Science Institute in Japan, qualifies the research as a tour de force study that will help address outstanding questions in the field.

More information: Julie St-Pierre, Mélanie Douziech, Franck Bazile, Mirela Pascariu, Éric Bonneil, Véronique Sauvé, Hery Ratsima and Damien D'Amours. Polo Kinase Regulates Mitotic Chromosome Condensation by Hyperactivation of Condensin DNA Supercoiling Activity, Molecular Cell (2009), 34, 416-426. doi:10.1016/j.molcel.2009.04.013.

Source: University of Montreal (news : web)

Explore further: Genomic analysis of prostate cancer indicates best course of action after surgery

add to favorites email to friend print save as pdf

Related Stories

Boost for new cancer therapies

Dec 14, 2006

Scientists have revealed the critical role a key enzyme plays in helping cells divide in what could prove an important breakthrough for new cancer therapies.

Researchers shed light on shrinking of chromosomes

Jun 11, 2007

A human cell contains an enormous 1.8 metres of DNA partitioned into 46 chromosomes. These have to be copied and distributed equally into two daughter cells at every division. Condensation, the shortening of chromosomes, ...

Matrimony inhibits Polo kinase

Dec 04, 2007

Suspended animation is something we only associate with Sci Fi programs, but something remarkably similar actually occurs in unfertilized egg cells, in the ovaries of animals as different as humans and fruit flies. In an ...

Potential new therapeutic molecular target to fight cancer

Nov 01, 2007

Researchers at the Virginia Commonwealth University Massey Cancer Center have identified the enzyme sphingosine kinase 2 as a possible new therapeutic target to improve the efficacy of chemotherapy for colon and breast cancer.

Recommended for you

Cancer: Tumors absorb sugar for mobility

8 hours ago

Cancer cells are gluttons. We have long known that they monopolize large amounts of sugar. More recently, it became clear that some tumor cells are also characterized by a series of features such as mobility or unlikeliness ...

Early hormone therapy may be safe for women's hearts

17 hours ago

(HealthDay)—Healthy women at low risk of cardiovascular disease may be able to take hormone replacement therapy soon after menopause for a short time without harming their hearts, according to a new study.

Low yield for repeat colonoscopy in some patients

18 hours ago

(HealthDay)—Repeat colonoscopies within 10 years are of little benefit to patients who had no polyps found on adequate examination; however, repeat colonoscopies do benefit patients when the baseline examination was compromised, ...

User comments : 0